Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Brain-Health Company IXICO Ready To Seize Pharma's Digital Health Opportunities

Executive Summary

Brain-health company IXICO is ready to seize pharma's digital health opportunities by expanding into the companion digital health product sector. Last year the company partnered with Biogen to pilot its digital platform Assessa with the drug TYSABRI.

You may also be interested in...

IXICO Aims To Scale Up In 2018

Brain health imaging company IXICO has outlined a five-point plan to scale business in a bid to deliver double digit revenue growth. With a new CEO at the helm, the UK company is looking to expand its network of pharma partners, increase its penetration of the clinical trials market and target later-stage clinical phases with its digital technologies.

Pharma Friend? IXICO Seeks To Boost MS Drug Sales With Brain Health Tech

IXICO has struck a partnership with a major pharma player to help improve clinical outcomes of the latter’s blockbuster drug for multiple sclerosis – which will hopefully lead to increased sales – by adding the use of IXICO’s Assessa digital brain health monitoring technology to better manage a serious and potentially fatal side effect of the therapy.

Specialists Advocate Helmet Ventilation For COVID-19 Hospital Treatment

Experts from the University of Chicago are advocating for helmet ventilation for COVID-19 patients. Medtech Insight spoke to acute nurse practitioner Aurika Savickaite who is helping lead an initiative to educate and raise awareness of the technology.



Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts